药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Fenoterol
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Carfilzomib.
Fenoterol
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Carfilzomib.
Fenoterol
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Carfilzomib.
Fenoterol
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Carfilzomib.
Fenoterol
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Carfilzomib.
Fenoterol
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Carfilzomib.
Fenoterol
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Carfilzomib.
Fenoterol
Tofacitinib
Carfilzomib may increase the immunosuppressive activities of Tofacitinib.
Fenoterol
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Carfilzomib.
Fenoterol
Ledipasvir
The serum concentration of Carfilzomib can be increased when it is combined with Ledipasvir.
Fenoterol
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Carfilzomib.
Fenoterol
Afatinib
The serum concentration of Carfilzomib can be increased when it is combined with Afatinib.
Fenoterol
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Carfilzomib.
Fenoterol
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Carfilzomib.
Fenoterol
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Carfilzomib.
Fenoterol
Roflumilast
Roflumilast may increase the immunosuppressive activities of Carfilzomib.
Fenoterol
Difluocortolone
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Difluocortolone.
Fenoterol
Clobetasol
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Clobetasol.
Fenoterol
Fluocortolone
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluocortolone.
Fenoterol
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Hydrocortisone butyrate.